Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

Why the FDA Wants to Stop Companies From Putting CBD in Everything

Por: Slate Science October 05, 2022

thumbnail

Pop open a seltzer or eat a cookie and feel extra relaxed—that’s the promise of CBD (aka “cannabidiol”)–infused drinks. Major food and beverage companies such as , , and have expressed interest in marketing CBD-infused food and drinks. While you might be able to find CBD beverages sold in some stores (it depends on where you live), you can’t walk into any supermarket in America and grab a pack of CBD cookies. CBD is a chemical... + full article



Similar News

Health Experts Recommend Japan To Consider Allowing Medical Cannabis

Forbes USA Life October 10, 2022

thumbnailHundreds of people join in a march calling for the legalization of marijuana in Tokyo, May 1, 2016. ... [+] People participated in the march calling for the legalization of marijuana, either for its medical benefits or for recreational purposes. The Global Marijuana March is an... + más

California wildfires threaten nearly all of state's cannabis crops | Newsweek

VJ Scientific Unveils New X-Ray Cannabis Decontamination Machine | Forbes


ALS drug wins FDA approval despite questionable data

ABC News USA Health September 30, 2022

thumbnailWASHINGTON -- A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.Amylyx Pharmaceuticals said the Food and... + más

Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post

ALS drug wins FDA approval despite questionable data | WPLG Local 10


ALS drug wins FDA approval despite questionable data

WPLG Local 10 USA Politics September 30, 2022

thumbnailWASHINGTON – A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration approved... + más

Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post

ALS drug wins FDA approval despite questionable data | ABC News


ALS drug wins FDA approval despite questionable data

Associated Press USA Science September 30, 2022

thumbnailWASHINGTON (AP) — A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration... + más

Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post

ALS drug wins FDA approval despite questionable data | ABC News


FDA concedes delays in response to baby formula shortage

WPLG Local 10 USA Health September 24, 2022

thumbnailWASHINGTON – The Food and Drug Administration acknowledged Tuesday that its response to the U.S. was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory.A 10-page report from the agency offers its first formal... + más

FDA concedes delays in response to baby formula shortage | ABC News

‘If the FDA is expected to do more, it needs more’: FDA investigation into baby-formula crisis points to its own shortcomings. But shortages persist. | MarketWatch


FDA concedes delays in response to baby formula shortage

ABC News USA Health September 21, 2022

thumbnailWASHINGTON -- The Food and Drug Administration acknowledged Tuesday that its response to the U.S. infant formula shortage was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory.A 10-page report from the agency... + más

FDA concedes delays in response to baby formula shortage | Associated Press

Internal FDA report on infant formula crisis details shortfalls in response | ABC News


FDA concedes delays in response to baby formula shortage

Associated Press USA Politics September 21, 2022

thumbnailWASHINGTON (AP) — The Food and Drug Administration acknowledged Tuesday that its response to the U.S. was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory.A 10-page report from the agency offers its first... + más

FDA concedes delays in response to baby formula shortage | ABC News

Internal FDA report on infant formula crisis details shortfalls in response | ABC News



About iurex | Privacy Policy | Disclaimer |